Difference between revisions of "Part:BBa K4768004"
Line 54: | Line 54: | ||
</div> | </div> | ||
</div> | </div> | ||
− | + | </div> | |
<h2>Characterisation</h2> | <h2>Characterisation</h2> | ||
<p>TXXXXXX.</p> | <p>TXXXXXX.</p> |
Revision as of 23:21, 7 October 2023
Recombinant Pyrimidine/purine nucleoside phosphorylase (ppnP) from E. coli
Biosensing inducible system to express E.coli nucleoside phosphorylase (ppnP) in PURE system
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Introduction
The part (BBa_K4768004) includes the E. coli Pyrimidine/purine nucleoside phosphorylase gene, controlled by a T7 promoter with an operator sequence called dhdO. This part is very important in our project because the encoded enzyme is responsible for the conversion of Tegafur (a prodrug) into 5-Fluorouracil (an active drug).
Construction
The ppnP gene was obtained from Dr. Baixing Wu, an Associate Professor at the RNA Biomedical Institute, Medical Research Center at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University. Dr. Wu is the author of the article titled "Crystal structures of a new class of pyrimidine/purine nucleoside phosphorylase revealed a Cupin fold" [1]. The ppnP gene was placed under the control of a T7 promoter with an operator site known as dhdO. The synthesis of the gBlock of this part was carried out and provided by IDT (Integrated DNA Technologies).
We amplified the gBlock by PCR using the following primers(from 5' to 3'):
Characterisation
TXXXXXX.
Conclusion and Perspectives
TXXXXXX.
References
- article 1 xxxxxxxx
- article 2 xxxxxxx